Literature DB >> 18491554

Adsorption of metallic radionuclides on plastic phantom walls.

Mi-Ae Park1, Ashfaq Mahmood, Robert E Zimmerman, Naengnoi Limpa-Amara, G Mike Makrigiorgos, Stephen C Moore.   

Abstract

Metal radionuclide solutions at neutral pH adhere to plastic containers. Adsorption of radionuclides on the walls of phantoms leads to a nonuniform activity distribution, which could adversely affect imaging studies, as well as phantom-based validations of absorbed dose calculations used in radioimmunotherapy, requiring accurate knowledge of the underlying activity distribution. In the work reported here, the authors determined the degree of metal chelation required to minimize metallic radionuclide oxide formation and adsorption on phantom walls in order to yield more reliable experimental data for validating image-based dosimetry. Using hollow spherical plastic phantoms, the authors evaluated three different radionuclides, I-131, In-111, and Y-90, in solutions containing three different concentrations of the chelator, ethylenediaminetetraacetate (EDTA). Adsorption to plastic walls was determined using microSPECT imaging and/or by counting aliquots of solutions. Reconstructed images and measurements of I-131 activity showed that it was uniformly distributed within all spheres; however, images of In-111 in 0.25-microM EDTA indicated that the activity concentration near the wall was much higher than that in the middle of the sphere. The decrease in activity concentration near the center of the spheres was approximately 47%. Y-90 in 0.25-microM EDTA behaved similarly; the activity concentration of Y-90 decreased by 46%. For an In-111 or Y-90 radioactivity concentration of 0.74 MBq/mL, a 2.5-microM EDTA solution was required to achieve a uniform distribution, suggesting that, under our experimental conditions, approximately 700 EDTA molecules were required for each radiometal atom to prevent precipitation and adsorption on poly(methylmethacrylate). For certain radiometals, e.g., In-111 or Y-90, adequate chelation is essential to achieve uniform activity concentration values and homogeneous distribution within the phantom compartments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491554      PMCID: PMC2673622          DOI: 10.1118/1.2871191

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  12 in total

1.  111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

Review 2.  Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection.

Authors:  Christopher J Palestro; Charito Love; Gene G Tronco; Maria B Tomas; Josephine N Rini
Journal:  Radiographics       Date:  2006 May-Jun       Impact factor: 5.333

3.  Accelerated image reconstruction using ordered subsets of projection data.

Authors:  H M Hudson; R S Larkin
Journal:  IEEE Trans Med Imaging       Date:  1994       Impact factor: 10.048

4.  Adsorption of some technetium-99m radiopharmaceuticals onto disposable plastic syringes.

Authors:  B A Jansson; M B Göransson; B N Agren
Journal:  J Nucl Med Technol       Date:  1998-09

5.  MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.

Authors:  W E Bolch; L G Bouchet; J S Robertson; B W Wessels; J A Siegel; R W Howell; A K Erdi; B Aydogan; S Costes; E E Watson; A B Brill; N D Charkes; D R Fisher; M T Hays; S R Thomas
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

6.  Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.

Authors:  Marion de Jong; Wout A P Breeman; Roelf Valkema; Bert F Bernard; Eric P Krenning
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

7.  Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer.

Authors:  D B Sodee; R Conant; M Chalfant; S Miron; E Klein; R Bahnson; J P Spirnak; B Carlin; E M Bellon; B Rogers
Journal:  Clin Nucl Med       Date:  1996-10       Impact factor: 7.794

8.  131I-tositumomab therapy as initial treatment for follicular lymphoma.

Authors:  Mark S Kaminski; Melissa Tuck; Judith Estes; Arne Kolstad; Charles W Ross; Kenneth Zasadny; Denise Regan; Paul Kison; Susan Fisher; Stewart Kroll; Richard L Wahl
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

Review 9.  Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma.

Authors:  T E Witzig
Journal:  Cancer Chemother Pharmacol       Date:  2001-08       Impact factor: 3.333

10.  Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.

Authors:  Yuni K Dewaraja; Scott J Wilderman; Michael Ljungberg; Kenneth F Koral; Kenneth Zasadny; Mark S Kaminiski
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

View more
  8 in total

1.  Development and evaluation of an improved quantitative (90)Y bremsstrahlung SPECT method.

Authors:  Xing Rong; Yong Du; Michael Ljungberg; Erwann Rault; Stefaan Vandenberghe; Eric C Frey
Journal:  Med Phys       Date:  2012-05       Impact factor: 4.071

2.  Activity quantification combining conjugate-view planar scintigraphies and SPECT/CT data for patient-specific 3-D dosimetry in radionuclide therapy.

Authors:  Yannick Berker; Andreas Goedicke; Gerrit J Kemerink; Til Aach; Bernd Schweizer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-08       Impact factor: 9.236

3.  Improved quantitative 90 Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling.

Authors:  Yuni K Dewaraja; Se Young Chun; Ravi N Srinivasa; Ravi K Kaza; Kyle C Cuneo; Bill S Majdalany; Paula M Novelli; Michael Ljungberg; Jeffrey A Fessler
Journal:  Med Phys       Date:  2017-10-28       Impact factor: 4.071

4.  What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy.

Authors:  Johannes Tran-Gia; Maikol Salas-Ramirez; Michael Lassmann
Journal:  J Nucl Med       Date:  2019-12-20       Impact factor: 10.057

5.  Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning.

Authors:  Britt Kunnen; Martijn M A Dietze; Arthur J A T Braat; Marnix G E H Lam; Max A Viergever; Hugo W A M de Jong
Journal:  Med Phys       Date:  2020-01-20       Impact factor: 4.071

6.  Y-90 SPECT ML image reconstruction with a new model for tissue-dependent bremsstrahlung production using CT information: a proof-of-concept study.

Authors:  Hongki Lim; Jeffrey A Fessler; Scott J Wilderman; Allen F Brooks; Yuni K Dewaraja
Journal:  Phys Med Biol       Date:  2018-05-22       Impact factor: 3.609

7.  Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization.

Authors:  Marco D'Arienzo; Maria Pimpinella; Marco Capogni; Vanessa De Coste; Luca Filippi; Emiliano Spezi; Nick Patterson; Francesca Mariotti; Paolo Ferrari; Paola Chiaramida; Michael Tapner; Alexander Fischer; Timo Paulus; Roberto Pani; Giuseppe Iaccarino; Marco D'Andrea; Lidia Strigari; Oreste Bagni
Journal:  EJNMMI Res       Date:  2017-11-28       Impact factor: 3.138

8.  Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals.

Authors:  Jill Wevrett; Andrew Fenwick; James Scuffham; Lena Johansson; Jonathan Gear; Susanne Schlögl; Marcel Segbers; Katarina Sjögreen-Gleisner; Pavel Solný; Michael Lassmann; Jill Tipping; Andrew Nisbet
Journal:  EJNMMI Phys       Date:  2018-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.